Flt1-12

General Information


DRACP ID  DRACP04972

Peptide Name   Flt1-12

Sequence  RPFVEMYSEIPE

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C68H101N15O21S

Absent amino acids  ACDGHKLNQTW

Common amino acids  E

Mass  169306

Pl  3.98

Basic residues  1

Acidic residues  3

Hydrophobic residues  3

Net charge  -2

Boman Index  -2460

Hydrophobicity  -57.5

Aliphatic Index  56.67

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  135.45

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 11311231

Title  A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor

Doi 10.1016/s0014-5793(01)02314-6

Year  2001

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.